# Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors

> **NCT00815945** · PHASE2 · COMPLETED · sponsor: **AGO Study Group** · enrollment: 41 (actual)

## Conditions studied

- Mesenchymal Tumor
- Carcinosarcoma
- Leiomyosarcoma

## Interventions

- **DRUG:** PegLiposomal Doxorubicin
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00815945
- **Lead sponsor:** AGO Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2011-11
- **Final completion:** 2012-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815945, "Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00815945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*